Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Research Microscopy Software

By Drug Discovery Trends Editor | November 13, 2012

Leica Microsystems has launched the new version of its research microscopy software LAS AF 3 (Leica Application Suite Advanced Fluorescence). LAS AF 3 covers the spectrum of fluorescence applications from routine work to sophisticated tasks in biomedical research, such as deep imaging of thicker tissue or interactive time lapse experiments.

A key feature of the LAS AF 3 is its modern user interface, optimized for fluorescence imaging. It reduces stray light from the computer screen disturbing light-sensitive experiments. The wizard based interface guides users safely and intuitively through data recording and evaluation. LAS LAS AF 3 offers full control over the microscope hardware while minimizing user interaction through intelligent automation, e.g. by opening and closing shutters according to the selected contrasting method. Matching DIC prisms are moved into the light path when changing objectives; in fluorescence mode the DIC prisms are automatically removed from the light path to obtain best image quality. All system parameters can be reloaded and applied to future experiments for maximal reproducibility. Both, intelligent automation and the ergonomic design of LAS AF reduce learning and training time thus allowing the user to focus on the research rather than on the software.

Due to the modular structure of LAS AF 3 systems can be tailored to fit specific needs. A wide choice of hardware components e.g. the unique water immersion micro dispenser, high precision stages and live-cell accessories can be added to obtain integrated and reliable system solutions dedicated to specific applications like screening, ratio imaging, FRET, colocalization studies, super-resolution and TIRF microscopy or electrophysiology.

All application, processing, and quantification modules such as the High Content Screening package (Leica HCS A) or the Live Data Mode for the definition of acquisition macros are fully integrated into LAS AF 3 for fast handling and visualization of large data sets.

LAS AF 3 like its predecessor supports both, the Leica widefield imaging platform and the confocal laser scanning system family Leica TCS SP8. One software user interface for all Leica systems sets ideal conditions for swift and effective work, which is particularly important in imaging facilities.

Harnessing the performance of modern graphic card processors, the new 3D Visualization package offers a wide variety of brilliant real-time 3D rendering options. Choose from functions such as fast rotation, display of 3D images on stereoscopic displays, interactive shadow projection, even combined with transparency projections, or editing of 4D data sets to produce impressive animated movie sequences.

Thanks to 64-bit technology, LAS AF 3 is fully equipped to provide fast image recording and brilliant results, even for large amounts of data. The wide range of tools for image processing, deconvolution and 3D visualization enables the user to capture and process all the important details of the sample without the need for additional software. The intuitive menu guidance proves helpful especially for the analysis and quantification of complex experiments.

Using LAS AF 3 software, researchers can get the most out of their microscope systems to obtain the best possible results and thus new scientific insights.

Leica Microsystems


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE